STE Overview

STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.

Wall Street analysts forecast STE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for STE is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

STERIS plc revenue for the last quarter amounts to 1.50B USD, increased 9.17

STERIS plc. EPS for the last quarter amounts to 1.96 USD, increased 12.00

STERIS plc (STE) has 17787 emplpoyees as of March 10 2026.

Today STE has the market capitalization of 22.33B USD.